vs
Side-by-side financial comparison of Dragonfly Energy Holdings Corp. (DFLI) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
Dragonfly Energy Holdings Corp. is the larger business by last-quarter revenue ($13.1M vs $9.1M, roughly 1.4× Protalix BioTherapeutics, Inc.). Protalix BioTherapeutics, Inc. runs the higher net margin — -60.3% vs -344.9%, a 284.5% gap on every dollar of revenue. On growth, Dragonfly Energy Holdings Corp. posted the faster year-over-year revenue change (6.9% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-14.9M). Over the past eight quarters, Dragonfly Energy Holdings Corp.'s revenue compounded faster (2.2% CAGR vs -6.7%).
Dragonfly Energy Holdings Corp. is a U.S.-based energy technology company specializing in designing and manufacturing high-performance, sustainable lithium-ion batteries. Its core offerings include deep-cycle batteries for RVs, marine uses, off-grid power systems, and residential energy storage, primarily serving consumer and small industrial renewable energy markets across North America.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
DFLI vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.1M | $9.1M |
| Net Profit | $-45.0M | $-5.5M |
| Gross Margin | 18.2% | 49.4% |
| Operating Margin | -78.1% | -51.1% |
| Net Margin | -344.9% | -60.3% |
| Revenue YoY | 6.9% | -49.9% |
| Net Profit YoY | -357.6% | -184.8% |
| EPS (diluted) | $-13.09 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.1M | $9.1M | ||
| Q3 25 | $16.0M | $17.9M | ||
| Q2 25 | $16.2M | $15.7M | ||
| Q1 25 | $13.4M | $10.1M | ||
| Q4 24 | $12.2M | $18.2M | ||
| Q3 24 | $12.7M | $18.0M | ||
| Q2 24 | $13.2M | $13.5M | ||
| Q1 24 | $12.5M | — |
| Q4 25 | $-45.0M | $-5.5M | ||
| Q3 25 | $-11.1M | $2.4M | ||
| Q2 25 | $-7.0M | $164.0K | ||
| Q1 25 | $-6.8M | $-3.6M | ||
| Q4 24 | $-9.8M | $6.5M | ||
| Q3 24 | $-6.8M | $3.2M | ||
| Q2 24 | $-13.6M | $-2.2M | ||
| Q1 24 | $-10.4M | — |
| Q4 25 | 18.2% | 49.4% | ||
| Q3 25 | 29.7% | 53.4% | ||
| Q2 25 | 28.3% | 62.5% | ||
| Q1 25 | 29.4% | 19.1% | ||
| Q4 24 | 20.8% | 78.7% | ||
| Q3 24 | 22.6% | 53.4% | ||
| Q2 24 | 24.0% | 29.8% | ||
| Q1 24 | 24.4% | — |
| Q4 25 | -78.1% | -51.1% | ||
| Q3 25 | -23.7% | 11.9% | ||
| Q2 25 | -20.2% | 7.5% | ||
| Q1 25 | -44.3% | -41.0% | ||
| Q4 24 | -58.5% | 39.6% | ||
| Q3 24 | -47.4% | 22.2% | ||
| Q2 24 | -51.1% | -18.0% | ||
| Q1 24 | -46.7% | — |
| Q4 25 | -344.9% | -60.3% | ||
| Q3 25 | -69.3% | 13.2% | ||
| Q2 25 | -43.3% | 1.0% | ||
| Q1 25 | -50.9% | -35.8% | ||
| Q4 24 | -80.6% | 35.6% | ||
| Q3 24 | -53.3% | 18.0% | ||
| Q2 24 | -103.2% | -16.4% | ||
| Q1 24 | -82.9% | — |
| Q4 25 | $-13.09 | $-0.06 | ||
| Q3 25 | $-0.20 | $0.03 | ||
| Q2 25 | $-0.58 | $0.00 | ||
| Q1 25 | $-0.93 | $-0.05 | ||
| Q4 24 | $-54.60 | $0.10 | ||
| Q3 24 | $-0.11 | $0.03 | ||
| Q2 24 | $-0.22 | $-0.03 | ||
| Q1 24 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.3M | $14.7M |
| Total DebtLower is stronger | $19.3M | — |
| Stockholders' EquityBook value | $11.5M | $48.2M |
| Total Assets | $86.5M | $82.3M |
| Debt / EquityLower = less leverage | 1.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.3M | $14.7M | ||
| Q3 25 | $3.8M | $13.6M | ||
| Q2 25 | $2.7M | $17.9M | ||
| Q1 25 | $2.5M | $19.5M | ||
| Q4 24 | $4.8M | $19.8M | ||
| Q3 24 | $8.0M | $27.4M | ||
| Q2 24 | $4.7M | $23.4M | ||
| Q1 24 | $8.5M | — |
| Q4 25 | $19.3M | — | ||
| Q3 25 | $97.1M | — | ||
| Q2 25 | $93.2M | — | ||
| Q1 25 | $89.5M | — | ||
| Q4 24 | $85.9M | — | ||
| Q3 24 | $82.4M | — | ||
| Q2 24 | $80.4M | — | ||
| Q1 24 | $77.1M | — |
| Q4 25 | $11.5M | $48.2M | ||
| Q3 25 | $-21.6M | $52.9M | ||
| Q2 25 | $-16.6M | $49.9M | ||
| Q1 25 | $-15.6M | $45.2M | ||
| Q4 24 | $-9.4M | $43.2M | ||
| Q3 24 | $-297.0K | $32.4M | ||
| Q2 24 | $5.3M | $28.6M | ||
| Q1 24 | $17.8M | — |
| Q4 25 | $86.5M | $82.3M | ||
| Q3 25 | $73.8M | $82.3M | ||
| Q2 25 | $71.8M | $78.5M | ||
| Q1 25 | $74.2M | $73.9M | ||
| Q4 24 | $75.2M | $73.4M | ||
| Q3 24 | $83.9M | $61.6M | ||
| Q2 24 | $85.0M | $91.5M | ||
| Q1 24 | $88.4M | — |
| Q4 25 | 1.68× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.27× | — | ||
| Q1 24 | 4.33× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.7M | $2.0M |
| Free Cash FlowOCF − Capex | $-14.9M | $1.6M |
| FCF MarginFCF / Revenue | -113.8% | 17.8% |
| Capex IntensityCapex / Revenue | 1.1% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.7M | $2.0M | ||
| Q3 25 | — | $-3.7M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | $-4.5M | $-5.1M | ||
| Q4 24 | $-2.5M | $4.0M | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | $-3.4M | — |
| Q4 25 | $-14.9M | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | $-5.3M | $-5.4M | ||
| Q4 24 | $-3.5M | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | -113.8% | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | -39.6% | -53.0% | ||
| Q4 24 | -28.6% | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | -33.7% | — |
| Q4 25 | 1.1% | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | 5.8% | 3.0% | ||
| Q4 24 | 8.1% | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 6.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFLI
| Original Equipment Manufacturers | $8.1M | 62% |
| Sales Channel Directly To Consumer | $4.7M | 36% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
